BIOCARTIS GROUP NV 144A-Reg S News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

09.05.24	Press release Biocartis Group NV: Biocartis Group NV provides an update regarding the publication of its annual report and the annual meeting (GlobeNewswire)
10.01.24	Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of large shareholdings) (GlobeNewswire)
10.01.24	Press release Biocartis Group NV: Disclosure of transparency notification (Article 14, first paragraph, of the Act of 2 May 2007 on the disclosure of major shareholdings) (GlobeNewswire)
22.11.23	Press release Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion (GlobeNewswire)
13.11.23	Press release Biocartis NV: Biocartis Hosts Corporate Workshop and Announces Seven Idylla™ Abstracts to be Presented at AMP 2023 Annual Meeting (GlobeNewswire)
31.10.23	Press release Biocartis Group NV: Announcement regarding Enforcement by Secured Creditors (GlobeNewswire)
20.10.23	Press release Biocartis Group NV: Four Abstracts Showing Excellent Data for Idylla™ Presented at European Society of Molecular Oncology Congress (ESMO) (GlobeNewswire)
16.10.23	Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio (GlobeNewswire)
12.10.23	Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit (GlobeNewswire)
03.10.23	Press Release Biocartis Group NV: Disclosure of transparency notification (GlobeNewswire)
26.09.23	Press Release Biocartis Group NV: Agreement regarding recapitalization of operating subsidiaries by secured by secured creditors and wind down of listed holding company (GlobeNewswire)
26.09.23	Press Release Biocartis Group NV: Biocartis announces H1 2023 Results and provides an update on the operational reorganization and recapitalization (GlobeNewswire)
21.09.23	Press release Biocartis Group NV: Biocartis 2023 half-year results webcast on 26 September 2023 (GlobeNewswire)
28.08.23	Press Release Biocartis Group NV: Biocartis appoints new Medical Advisory Board (MAB) of renowned practice leaders (GlobeNewswire)
24.08.23	Press Release Biocartis Group NV: Biocartis Announces 2023 Half-Year Results on 26 September 2023 (GlobeNewswire)
10.08.23	Press Release Biocartis Group NV: Biocartis Partners with Lilly to Explore Biomarker Testing for NSCLC Patients using the Idylla™ Platform (GlobeNewswire)
18.07.23	Press release Biocartis Group NV: Biocartis appoints George Cardoza as new CFO and Head of Service Delivery (GlobeNewswire)
30.06.23	Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities (GlobeNewswire)
20.06.23	Press release Biocartis Group NV: Disclosure of transparency notification (GlobeNewswire)
15.06.23	Press release Biocartis Group NV: Biocartis announces planned operational reorganization and cost reduction program (GlobeNewswire)
08.06.23	Press release Biocartis Group NV: Disclosure of transparency notification (GlobeNewswire)
05.06.23	Press release Biocartis Group NV: Biocartis announces resignation CFO (GlobeNewswire)
12.05.23	Press release Biocartis Group NV: Results of the Annual Shareholders’ Meeting held on 12 May 2023 (GlobeNewswire)
09.05.23	Press release Biocartis Group NV: Biocartis and HiloProbe to Collaborate on Colorectal Cancer Test (GlobeNewswire)
28.04.23	Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities (GlobeNewswire)
20.04.23	Press release Biocartis Group NV: Biocartis Reports Results of First Quarter of 2023 (GlobeNewswire)
11.04.23	Press release Biocartis Group NV: Biocartis appoints Roger Moody as new CEO (GlobeNewswire)
11.04.23	Press release Biocartis Group NV: Invitation to the Annual Shareholders’ Meeting (GlobeNewswire)
11.04.23	Press release Biocartis Group NV: Biocartis Announces Publication of 2022 Annual Report (GlobeNewswire)
04.04.23	Press release Biocartis Group NV: Biocartis and APIS Assay Technologies Sign Collaboration to Develop and Commercialise a Breast Cancer Subtyping Test on the Idylla™ platform (GlobeNewswire)
31.03.23	Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities (GlobeNewswire)
29.03.23	Press release Biocartis Group NV: Biocartis To Publish 2022 Annual Report on 11 April 2023 (GlobeNewswire)
03.03.23	Press release Biocartis Group NV: Disclosure of transparency notification (GlobeNewswire)
02.03.23	Press release Biocartis Group NV: Biocartis announces the US FDA 510(k) clearance for the Idylla™ MSI Test (GlobeNewswire)
28.02.23	Press release Biocartis Group NV: Disclosure of Outstanding Voting Securities (GlobeNewswire)
24.02.23	Press release Biocartis Group NV: Biocartis Creates New Share Option Plan and Cancels Outstanding Pool under Existing Share Option Plans (GlobeNewswire)
23.02.23	Press release Biocartis Group NV: Biocartis announces 2022 results and 2023 outlook (GlobeNewswire)
22.02.23	Press release Biocartis Group NV: Biocartis announces change in Board composition (GlobeNewswire)
16.02.23	Press release Biocartis Group NV: Biocartis Announces 2022 Full Year Results on 23 February 2023 (GlobeNewswire)
09.02.23	Press release Biocartis Group NV: Biocartis Announces the Launch of the First Assay Developed With the New Idylla™ Flex Technology (GlobeNewswire)
09.04.19	Biocartis Group NV: Invitation to Annual Shareholders' Meeting (GlobeNewswire)
05.04.19	Biocartis Group NV: DISCLOSURE OF OUTSTANDING VOTING SECURITIES (GlobeNewswire)
04.04.19	Biocartis Group NV: Biocartis announces publication of its 2018 annual report (GlobeNewswire)
12.03.19	Biocartis Group NV: Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies (GlobeNewswire)
28.02.19	Biocartis Group NV: BIOCARTIS ANNOUNCES 2018 RESULTS AND 2019 OUTLOOK (GlobeNewswire)
23.01.19	Biocartis Group NV: BIOCARTIS SUCCESSFULLY RAISES EUR 55.50 MILLION (GlobeNewswire)
23.01.19	Biocartis Group NV: BIOCARTIS UPSIZES ITS EQUITY PLACEMENT DUE TO SIGNIFICANT DEMAND (GlobeNewswire)
23.01.19	Biocartis Group NV: BIOCARTIS LAUNCHES EQUITY PLACEMENT (GlobeNewswire)
07.01.19	Biocartis Group NV: Biocartis Announces Achieving its 2018 Key Business Objectives (GlobeNewswire)
29.10.18	Biocartis Group NV: Shareholding Disclosure (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu BIOCARTIS GROUP NV 144A-Reg S

Aktien Top/Flop

Meistgelesene Nachrichten